Calories, carbohydrates, and cancer therapy with radiation: Exploiting the five R's through dietary manipulation

Cancer and Metastasis Reviews

Volumn 33, Issue 1, 2014, Pages 217-229

  Klement, Rainer J ^a   Champ, Colin E ^b  

^a Second Department of Medicine   (Germany)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Calorie restriction; Ketogenic diet; Metabolism; Radiotherapy

Indexed keywords

CARBOHYDRATE; DNA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; KETONE BODY; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; CARBOHYDRATE DIET; OXYGEN;

CALORIC RESTRICTION; CANCER CONTROL; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL CYCLE; CELL POPULATION; CELLULAR DISTRIBUTION; CLINICAL PRACTICE; DIETARY INTAKE; DNA DAMAGE; DNA REPAIR; GLYCOLYSIS; HUMAN; KETOGENIC DIET; LOW CARBOHYDRATE DIET; METABOLISM; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROBABILITY; REOXYGENATION; REVIEW; TREATMENT RESPONSE; TUMOR CELL; TUMOR VASCULARIZATION; ADMINISTRATION AND DOSAGE; CARBOHYDRATE DIET; CELL PROLIFERATION; GENETICS; NEOPLASMS; RADIATION DOSE; RADIATION RESPONSE;

CALORIC RESTRICTION; CELL CYCLE; CELL PROLIFERATION; DIETARY CARBOHYDRATES; DNA REPAIR; HUMANS; KETOGENIC DIET; NEOPLASMS; OXYGEN; RADIATION TOLERANCE;

EID: 84899977976     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-014-9495-3     Document Type: Review

References (114)

1. Meijer, T. W. H., Kaanders, J. H. A. M., Span, P. N., & Bussink, J. (2012). Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clinical Cancer Research, 18, 5585-5594.
2. Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011). Lactate: a metabolic key player in cancer. Cancer Research, 71, 6921-6925.
3. Pitroda, S. P., Wakim, B. T., Sood, R. F., Beveridge, M. G., Beckett, M. A., Macdermed, D. M., et al. (2009). STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect. BMC Medicine, 7, 68.
4. Warburg, O. (1925). Über den Stoffwechsel der Carcinomzelle. Klinische Wochenschrift, 4, 534-536.
5. Warburg, O., Wind, F., Negelein, E. (1926). Über den Stoffwechsel der Tumoren im Körper. Klinische Wochenschrift, 5, 828-832.
6. Yuneva, M. (2008). Finding an "Achilles' heel" of cancer: the role of glucose and glutamine metabolism in the survival of transformed cells. Cell Cycle, 7, 2083-2089.
7. Choi, N. C., Fischman, A. J., Niemierko, A., Ryu, J. S., Lynch, T., Wain, J., et al. (2002). Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, and Physics, 54, 1024-1035.
8. Kunkel, M., Reichert, T. E., Benz, P., Lehr, H.-A., Jeong, J.-H., Wieand, S., et al. (2003). Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer, 97, 1015-1024.
9. Kubicek, G. J., Champ, C., Fogh, S., Wang, F., Reddy, E., Intenzo, C., et al. (2010). FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head & Neck Oncology, 2, 19.
10. Bentzen, S. M., & Gregoire, V. (2011). Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Seminars in Radiation Oncology, 21, 101-110.
11. Crabtree, H. G., & Cramer, W. (1933). The action of radium on cancer cells. II - some factors determining the susceptibility of cancer cells to radium. Proceedings of the Royal Society of London Ser B, Contain Pap a Biol Character, 113, 238-250.
12. Dang, C. V. (2012). Links between metabolism and cancer. Genes and Development, 26, 877-890.
13. Djiogue, S., Kamdje, A. H. N., Vecchio, L., Kipanyula, M. J., Farahna, M., Aldebasi, Y., et al. (2013). Insulin resistance and cancer: the role of insulin and IGFs. Endocrine-Related Cancer, 20, R1-R17.
14. Dwarakanath, B. S., Singh, D., Banerji, A. K., Sarin, R., Venkataramana, N. K., Jalali, R., et al. (2009). Clinical studies for improving radiotherapy with 2-deoxy-d-glucose: present status and future prospects. Journal of Cancer Research Theraphy, 5, 21-26.
15. El Mjiyad, N., Caro-Maldonado, A., Ramirez-Peinado, S., & Muñoz-Pinedo, C. (2011). Sugar-free approaches to cancer cell killing. Oncogene, 30, 253-264.
16. Zhao, Y., Butler, E. B., & Tan, M. (2013). Targeting cellular metabolism to improve cancer therapeutics. Cell Death & Disease, 4, e532.
17. Seyfried, T. N., Kiebish, M., Mukherjee, P., & Marsh, J. (2008). Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets. Epilepsia, 49(Suppl 8), 114-116.
18. Seyfried, T. N., & Shelton, L. M. (2010). Cancer as a metabolic disease. Nutrition and Metabolism, 7, 7.
19. Champ, C. E., Baserga, R., Mishra, M. V., Jin, L., Sotgia, F., Lisanti, M. P., et al. (2013). Nutrient restriction and radiation therapy for cancer treatment: when less is more. The Oncologist, 18, 97-103.
20. Fontana, L., Partridge, L., & Longo, V. D. (2013). Extending healthy lifespan - from yeast to humans. Science, 328, 321-326.
21. Saleh, A. D., Simone, B. A., Savage, J., Sano, Y., Jin, L., Champ, C., et al. (2013). Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle, 12, 1955-1963.
22. Klement, R. J., & Kämmerer, U. (2011). Is there a role for carbohydrate restriction in the treatment and prevention of cancer? Nutrition and Metabolism, 8, 75.
23. Mahoney, L. B., Denny, C. A., & Seyfried, T. N. (2006). Calorie restriction in C57BL/6J mice mimics therapeutic fasting in humans. Lipids in Health and Disease, 5, 13.
24. Smith, W. J., Underwood, L. E., & Clemmons, D. R. (1995). Effects of caloric or protein restriction on insulin-like growth factor-1 (IGF-1) and IGF-binding proteins in children and adults. Journal of Clinical Endocrinology and Metabolism, 80, 443-449.
25. Fontana, L., Weiss, E. P., Villareal, D. T., Klein, S., & Holloszy, O. (2009). Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentrations in humans. Aging Cell, 7, 681-687.
26. Fraser, D. A., Thoen, J., Bondhus, S., Haugen, M., Reseland, J. E., Djoseland, O., et al. (2000). Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients. Clinical and Experimental Rheumatology, 18, 209-214.
27. Volek, J. S., Sharman, M. J., Love, D. M., Avery, N. G., Gómez, A. L., Scheett, T. P., et al. (2002). Body composition and hormonal responses to a carbohydrate-restricted diet. Metabolism, 51, 864-870.
28. Klein, S., & Wolfe, R. R. (1992). Carbohydrate restriction regulates the adaptive response to fasting. American Journal of Physiology, 262, E631-E636.
29. Wilder, R. M. (1921). The effect of ketonemia on the course of epilepsy. Mayo Clinic Bulletin, 2, 307.
30. Westman, E. C., Mavropoulos, J., Yancy, W. S., & Volek, J. S. (2003). A review of low-carbohydrate ketogenic diets. Current Atherosclerosis Reports, 5, 476-483.
31. Feinman, R. D. (2005). When is a high fat diet not a high fat diet? Nutrition and Metabolism, 2, 27.
32. Cullingford, T. E. (2004). The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins, Leukotrienes and Essential Fatty Acids, 70, 253-264.
33. Rajaram, S., Baylink, D. J., & Mohan, S. (1997). Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocrine Reviews, 18, 801-831.
34. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-674.
35. Sengupta, S., Peterson, T. R., Laplante, M., Oh, S., & Sabatini, D. M. (2010). mTORC1 controls fasting-induced ketogenesis and its modulation by aging. Nature, 468, 1100-1104.
36. Cantó, C., Gerhart-hines, Z., Feige, J. N., Lagouge, M., Milne, J. C., Elliott, P. J., et al. (2009). AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 458, 1056-1060.
37. Kitada, M., Kume, S., Takeda-Watanabe, A., Tsuda, S., Kanasaki, K., & Koya, D. (1830). Calorie restriction in overweight males ameliorates obesity-related metabolic alterations and cellular adaptations through anti-aging effects, possibly including AMPK and SIRT1 activation. Biochimica et Biophysica Acta, 2013, 4820-4827.
38. Draznin, B., Wang, C., Adochio, R., Leitner, J. W., & Cornier, M.-A. (2012). Effect of dietary macronutrient composition on AMPK and SIRT1 expression and activity in human skeletal muscle. Hormone and Metabolic Research, 44, 650-655.
39. Bergouignan, A., Gozansky, W. S., Barry, D. W., Leitner, W., MacLean, P. S., Hill, J. O., et al. (2012). Increasing dietary fat elicits similar changes in fat oxidation and markers of muscle oxidative capacity in lean and obese humans. PLoS ONE, 7, e30164.
40. Hardie, D. G. (2011). Sensing of energy and nutrients by AMP-activated protein kinase. American Journal of Clinical Nutrition, 93(suppl), 891S-896S.
41. McDaniel, S. S., Rensing, N. R., Thio, L. L., Yamada, K. A., & Wong, M. (2011). The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia, 52, e7-e11.
42. Moore, T., Beltran, L., Carbajal, S., Strom, S., Traag, J., Hursting, S. D., et al. (2008). Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues. Cancer Prevention Research, 1, 65-76.
43. Steel, G. G., McMillan, T. J., & Peacock, J. H. (1989). The 5Rs of radiobiology. International Journal of Radiation Biology, 56, 1045-1048.
44. Safdie, F., Brandhorst, S., Wei, M., Wang, W., Lee, C., Hwang, S., et al. (2012). Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS ONE, 7, e44603.
45. Abdelwahab, M. G., Fenton, K. E., Preul, M. C., Rho, J. M., Lynch, A., Stafford, P., et al. (2012). The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS ONE, 7, e36197.
46. Allen, B. G., Bhatia, S. K., Buatti, J. M., Cancer, C., Published, R., & June, O. (2013). Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clinical Cancer Research, 19, 3905-3913.
47. Raffaghello, L., Lee, C., Safdie, F. M., Wei, M., Madia, F., Bianchi, G., et al. (2008). Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proceedings of the National Academy of Sciences, 105, 8215-8220.
48. Safdie, F. M., Dorff, T., Quinn, D., Fontana, L., Wei, M., Lee, C., et al. (2009). Fasting and cancer treatment in humans: a case series report. Aging (Albany NY), 1, 988-1007.
49. Raffaghello, L., Safdie, F., Bianchi, G., Dorff, T., Fontana, L., & Longo, V. D. (2010). Fasting and differential chemotherapy protection in patients. Cell Cycle, 9, 4474-4476.
50. Lee, C., Safdie, F. M., Raffaghello, L., Wei, M., Madia, F., Parrella, E., et al. (2010). Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Research, 70, 1564-1572.
51. Lee, C, Raffaghello, L, Brandhorst, S, Safdie, FM, Bianchi, G, Martin-Montalvo, A, et al. (2012) Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Science Translational Medicine, 4:124ra27.
52. Heydari, A. R., Unnikrishnan, A., Lucente, L. V., & Richardson, A. (2007). Caloric restriction and genomic stability. Nucleic Acids Research, 35, 7485-7496.
53. Frankenberg-Schwager, M., Frankenberg, D., & Harbich, R. (1985). Potentially lethal damage, sublethal damage and DNA double strand breaks. Radiation Protection Dosimetry, 13, 171-174.
54. Olive, P. (1998). The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. Radiation Research, 150, S42-S51.
55. Lee, J.-E., Heo, J.-I., Park, S.-H., Kim, J.-H., Kho, Y.-J., Kang, H.-J., et al. (2011). Calorie restriction (CR) reduces age-dependent decline of non-homologous end joining (NHEJ) activity in rat tissues. Experimental Gerontology, 46, 891-896.
56. Um JH, Kim SJ, Kim DW, Ha MY, Jang JH, Kim DW, et al. Tissue-specific changes of DNA repair protein Ku and mtHSP70 in aging rats and their retardation by caloric restriction. Mechanisms of Aging and Development, 124, 967-975.
57. Yamaza, H., Komatsu, T., Wakita, S., Kijogi, C., Park, S., Hayashi, H., et al. (2010). FoxO1 is involved in the antineoplastic effect of calorie restriction. Aging Cell, 9, 372-382.
58. Jeong, J., Juhn, K., Lee, H., Kim, S., Min, B., Lee, K., et al. (2007). SIRT1 promotes DNA repair activity and deacetylation of Ku70. Experimental and Molecular Medicine, 39, 8-13.
59. Kalaany, N. Y., & Sabatini, D. M. (2009). Tumours with PI3K activation are resistant to dietary restriction. Nature, 458, 725-731.
60. Chen, H., Ma, Z., Vanderwaal, R. P., Feng, Z., Gonzalez-Suarez, I., Wang, S., et al. (2011). The mTOR inhibitor rapamycin suppresses DNA double-strand break repair. Radiation Research, 175, 214-224.
61. Jiang, W., Zhu, Z., & Thompson, H. J. (2008). Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Research, 68, 5492-5499.
62. Song, C. W., Lee, H., Dings, R. P. M., Williams, B., Powers, J., Santos, T. D., et al. (2012). Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Scientific Reports, 2, 362.
63. Chi, A., Tome, W. A., Fowler, J., Komaki, R., Nguyen, N. P., Mehta, M. P., et al. (2011). Stereotactic body radiation therapy in non-small-cell lung cancer. American Journal of Clinical Oncology, 34, 432-441.
64. Armpilia, C. I., Dale, R. G., & Jones, B. (2004). Determination of the optimum dose per fraction in fractionated radiotherapy when there is delayed onset of tumour repopulation during treatment. British Journal of Radiology, 77, 765-767.
65. Fowler, J. F., Tomé, W. A., Fenwick, J. D., & Mehta, M. P. (2004). A challenge to traditional radiation oncology. International Journal of Radiation Oncology, Biology, and Physics, 60, 1241-1256.
66. Fine, E. J., Segal-Isaacson, C. J., Feinman, R. D., Herszkopf, S., Romano, M. C., Tomuta, N., et al. (2012). Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition, 28, 1028-1035.
67. Nogueira, L. M., Lavigne, J. A., Chandramouli, G. V. R., Lui, H., Barrett, J. C., & Hurstling, S. D. (2012). Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1. Cancer Medicine, 1, 275-288.
68. Chu-Shore, C. J., & Thiele, E. A. (2010). Tumor growth in patients with tuberous sclerosis complex on the ketogenic diet. Brain and Development, 32, 318-322.
69. Rossi-Fanelli, F., Franchi, F., Mulieri, M., Cangiano, C., Cascino, A., Ceci, F., et al. (1991). Effect of energy substrate manipulation on tumor cell proliferation in parenterally fed cancer patients. Clinical Nutrition, 10, 228-232.
70. Zuccoli, G., Marcello, N., Pisanello, A., Servadei, F., Vaccaro, S., Mukherjee, P., et al. (2010). Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report. Nutrition and Metabolism, 7, 33.
71. Demetrakopoulos, G., Linn, B., & Amos, H. (1978). Rapid loss of ATP by tumor cells deprived of glucose: contrast to normal cells. Biochemical and Biophysical Research Communications, 82, 787-794.
72. Shim, H., Chun, Y. S., Lewis, B. C., & Dang, C. V. (1998). A unique glucose-dependent apoptotic pathway induced by c-Myc. Proceedings of the National Academy of Sciences, 95, 1511-1516.
73. 2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochemical Journal, 418, 29-37.
74. Li, Y., Liu, L., & Tollefsbol, T. O. (2010). Glucose restriction can extend normal cell lifespan and impair precancerous cell growth through epigenetic control of hTERT and p16 expression. FASEB Journal, 24, 1442-1453.
75. Priebe, A., Tan, L., Wahl, H., Kueck, A., He, G., Kwok, R., et al. (2011). Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells. Gynecologic Oncology, 122, 389-395.
76. Graham, N. A., Tahmasian, M., Kohli, B., Komisopoulou, E., Zhu, M., & Vivanco, I. (2012). Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death. Molecular Systems Biology, 8, 589.
77. Fine, E. J., Miller, A., Quadros, E. V., Sequeira, J. M., & Feinman, R. D. (2009). Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell International, 9, 14.
78. Nebeling, L., Miraldi, F., Shurin, S., & Lerner, E. (1995). Effects of a ketogenic diet on tumor metabolism and nuritional status in pediatric oncology patients: two case reports. Journal of the American College of Nutrition, 14, 202-208.
79. Liang, J., & Slingerland, J. M. (2003). Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle, 2, 339-345.
80. Kandel, E. S., Skeen, J., Majewski, N., Di Cristofano, A., Pandolfi, P. P., Claudine, S., et al. (2002). Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage. Molecular and Cellular Biology, 22, 7831-7841.
81. Liang, Y., Liu, J., & Feng, Z. (2013). The regulation of cellular metabolism by tumor suppressor p53. Cell & Bioscience, 3, 9.
82. Apontes, P., Leontieva, O. V., Demidenko, Z. N., Li, F., & Blagosklonny, M. V. (2011). Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture. Oncotarget, 2, 222-233.
83. Li, Y., & Tollefsbol, T. O. (2011). p16 INK4a suppression by glucose restriction contributes to human cellular lifespan extension through SIRT1-mediated epigenetic and genetic mechanisms. PLoS ONE, 6, e17421.
84. Laplante, M., & Sabatini, D. M. (2009). mTOR signaling at a glance. Journal of Cell Science, 122, 3589-3594.
85. Harada, H., Itasaka, S., Kizaka-Kondoh, S., Shibuya, K., Morinibu, A., Shinomiya, K., et al. (2009). The Akt/mTOR pathway assures the synthesis of HIF-1α protein in a glucose- and reoxygenation-dependent manner in irradiated tumors. Journal of Biological Chemistry, 284, 5332-5342.
86. Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., et al. (2011). Normalization of the vasculature for treatment of cancer and other diseases. Physiological Reviews, 91, 1071-1121.
87. Mukherjee, P., Sotnikov, A. V., Mangian, H. J., Zhou, J., Visek, W. J., & Clinton, S. K. (1999). Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression. Journal of the National Cancer Institute, 91, 512-523.
88. Mukherjee, P., Abate, L. E., & Seyfried, T. N. (2004). Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clinical Cancer Research, 10, 5622-5629.
89. Urits, I., Mukherjee, P., Meidenbauer, J., & Seyfried, T. N. (2012). Dietary restriction promotes vessel maturation in a mouse astrocytoma. Journal of Oncology, 2012, 264039.
90. Bennett, M., Feldmeier, J., Smee, R., & Milross, C. (2012). Hyperbaric oxygenation for tumour sensitisation to radiotherapy. Cochrane Database of Systematic Reviews, 4, CD005007.
91. Poff, A. M., Ari, C., Seyfried, T. N., & Agostino, D. P. D. (2013). The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS ONE, 8, e65522.
92. Veech, R. L., Chance, B., Kashiwaya, Y., Lardy, H. A., & Cahill, G. F. (2001). Ketone bodies, potential therapeutic uses. IUBMB Life, 51, 241-247.
93. Veech, R. L. (2004). The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins, Leukotrienes and Essential Fatty Acids, 70, 309-319.
94. Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., et al. (2013). Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science, 339, 211-214.
95. Tisdale, M. J., & Brennan, R. A. (1983). Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. British Journal of Cancer, 47, 293-297.
96. Skinner, R., Trujillo, A., Ma, X., & Beierle, E. A. (2009). Ketone bodies inhibit the viability of human neuroblastoma cells. Journal of Pediatric Surgery, 44, 212-216.
97. Maurer, G. D., Brucker, D. P., Bähr, O., Harter, P. N., Hattingen, E., Walenta, S., et al. (2011). Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer, 11, 315.
98. Chang, H. T., Olson, L. K., & Schwartz, K. A. (2013). Ketolytic and glycolytic enzymatic expression profiles in malignant gliomas: implication for ketogenic diet therapy. Nutrition and Metabolism, 10, 47.
99. Sattler, U. G. A., Meyer, S. S., Quennet, V., Hoerner, C., Knoerzer, H., Fabian, C., et al. (2010). Glycolytic metabolism and tumour response to fractionated irradiation. Radiotherapy and Oncology, 94, 102-109.
100. Vlashi, E., Lagadec, C., Vergnes, L., Matsutani, T., Masui, K., & Poulou, M. (2011). Metabolic state of glioma stem cells and nontumorigenic cells. Proceedings of the National Academy of Sciences, 108, 16062-16067.
101. Stanley, K. E. (1980). Prognostic factors for survival in patients with inoperable lung cancer. Journal of the National Cancer Institute, 65, 25-32.
102. Ligibel, J. A., & Goodwin, P. J. (2012). NEW and RENEW: building the case for weight loss in breast cancer. Journal of Clinical Oncology, 30, 2294-2296.
103. Champ, C. E., Volek, J. S., Siglin, J., Jin, L., & Simone, N. L. (2012). Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data? International Journal of Breast Cancer, 2012, 506868.
104. Fontana, L., Partridge, L., & Longo, V. D. (2010). Extending healthy life span - from yeast to humans. Science, 328, 321-326.
105. Reed, M. J., Penn, P. E., Li, Y., Birnbaum, R., Vernon, R. B., Johnson, T. S., et al. (1996). Enhanced cell proliferation and biosynthesis mediate improved wound repair in refed, caloric-restricted mice. Mechanisms of Ageing and Development, 89, 21-43.
106. Kalm, L. M., & Semba, R. D. (2005). They starved so that others be better fed: remembering Ancel Keys and the Minnesota Experiment. Journal of Nutrition, 135, 1347-1352.
107. Simone, B. A., Champ, C. E., Rosenberg, A. L., Berger, A. C., Anne, R. P., Monti, D. A., et al. (2013). Selectively starving cancer cells through dietary manipulation: methods and clinical implications. Future Oncology, 9, 959-976.
108. Beck, S. A., & Tisdale, M. J. (1989). Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Research, 49, 3800-3804.
109. Barber, M. D., McMillan, D. C., Preston, T., Ross, J. A., & Fearon, K. C. (2000). Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clinical Science, 98, 389-399.
110. Breitkreutz, R., Tesdal, K., Jentschura, D., Haas, O., Leweling, H., & Holm, E. (2005). Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: a randomized controlled study. Wiener Klinische Wochenschrift, 117, 685-692.
111. Klement, RJ, Frobel, T, Albers, T, Fikenzer, S, Prinzhausen, J (2013) A pilot case study on the impact of a self-prescribed ketogenic diet on biochemical parameters and running performance in healthy and physically active individuals. Nutrition and Medicine, 1(1).
112. Gupta, D., Lammersfeld, C. A., Burrows, J. L., Dahlk, S. L., Vashi, P. G., Grutsch, J. F., et al. (2004). Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. American Journal of Clinical Nutrition, 80, 1634-1638.
113. Gupta, D., Lammersfeld, C. A., Vashi, P. G., King, J., Dahlk, S. L., Grutsch, J. F., et al. (2008). Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer, 8, 249.
114. Hite, A. H., Berkowitz, V. G., & Berkowitz, K. (2011). Low-carbohydrate diet review: shifting the paradigm. Nutrition in Clinical Practice, 26, 300-308.